Cancer Treatment Research in Tennessee
Cancer Treatment Research (93.395) awarded $117 million to recipients in Tennessee in 55 grants from fiscal 2021 to 2025, 2.1% of the program's national total. St Jude Children's Research Hospital Inc received the most, $67.9 million.
- Awarded in Tennessee$117 million
- Awards55
- Share of the program2.1%
- Rank among states14th of 50
- National total$5.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 29 | $19.3 million |
| FY 2022 | 30 | $23.7 million |
| FY 2023 | 35 | $27.2 million |
| FY 2024 | 33 | $23.1 million |
| FY 2025 | 34 | $23.9 million |
Recipients in Tennessee
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| St Jude Children's Research Hospital Inc | Nonprofits | 18 | $67.9 million |
| Vanderbilt University Medical Center | Nonprofits | 12 | $18.0 million |
| Vanderbilt University | Colleges and universities | 10 | $15.3 million |
| University of Tennessee | Colleges and universities | 10 | $14.0 million |
| East Tennessee State University | Colleges and universities | 1 | $1.0 million |
| Middle Tennessee State University | Colleges and universities | 2 | $511,115 |
| Seak Therapeutics, LLC | Small businesses | 1 | $399,981 |
| St. Jude Children's Research Hospital Graduate School of Biomedical Sciences, LLC | Nonprofits | 1 | $127,300 |
Open opportunities under this program
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
- Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
See all 47 on the program page
Questions people ask
How much Cancer Treatment Research money goes to Tennessee?
$117 million from fiscal 2021 to 2025, across 55 awards. Tennessee ranks 14th of 50 states and territories for this program.
Who receives Cancer Treatment Research money in Tennessee?
The largest recipient is St Jude Children's Research Hospital Inc, with $67.9 million in 18 awards. Next are Vanderbilt University Medical Center and Vanderbilt University.
Can organizations in Tennessee apply now?
Yes, 47 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Treatment Research in other states
Other large programs in Tennessee
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Child Care and Development Block Grant
- Children's Health Insurance Program
- Title I Grants to Local Educational Agencies
- Special Education Grants to States
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Head Start